Alaya.bio

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.alaya.bio/

Last Round

Series A

Jul 10, 2026

Total Funding Raised

$9.5M

Company Overview

Alaya.bio is a biotechnology company developing a proprietary polymeric nanoparticle platform for in-vivo CAR-T cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

in vivo gene deliveryCAR-T immunotherapypolymeric nanoparticlesin vivo CAR-Tgene therapycell engineeringlentiviral vectorsimmuno-oncologydrug delivery platformbiotech licensingin situ reprogrammingnext-gen CAR-Toff-the-shelf CAR-Tnanomedicinebiotech partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alaya.bio Comparables

Compare Alaya.bio with similar companies based on industry and business-model similarity.

Alaya.bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Aera Therapeutics	86%
Abintus Bio	82%
Ensoma	82%

View all Comparables

Alaya.bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jul 10, 2026
Seed	Dec 1, 2022
Pre Seed	Aug 8, 2022

View all Funding Rounds

Alaya.bio Investors

Notable investors and investment history

Alaya.bio investors
Investor	Rounds
Agoranov	Seed
Mission BioCapital	Pre Seed
Volnay Therapeutics	Pre Seed, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Aug 8, 2022
$3M round led by Mission BioCapital and Volnay Therapeutics.

View all signals

Alaya.bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Alaya.bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alaya.bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range24

Year Founded2022

Last FundingJul 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.